Abstract
SUMMARY Since its introduction, insulin therapy for diabetes has long been equated with pain, anxiety, lifestyle inconvenience and potential injection-site irritation and lipodystrophy. Efforts to develop noninvasive methods for insulin delivery have relied on molecular modifications, absorption enhancers and encapsulation techniques to resist degradation, promote drug penetration and achieve therapeutic plasma insulin levels. Product development attempts have targeted virtually every mucosal membrane in the body for potential drug delivery. Each administration route has unique physiologic constraints. Potential alternative insulin therapies are discussed with their respective technical challenges. An overview of new drug-delivery platforms currently in development is also provided.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.